In summary, human PAX1 deficiency causes syndromic features and SCID/CID characterized by impaired T cell development and susceptibility to infections, autoimmunity, and malignancy, with variable clinical penetrance of the different features. Here, PAX1 is linked to severe combined immunodeficiency.